INVIBIO LIMITED

04088050
Active Cleveleys

Manufacture of plastics in primary forms

15 employees website.com
Life sciences and medical technology Manufacture of plastics in primary forms
I

INVIBIO LIMITED

04088050

Manufacture of plastics in primary forms

Founded 11 Oct 2000 Active Cleveleys, United Kingdom 15 employees website.com
Life sciences and medical technology Manufacture of plastics in primary forms

Previous Company Names

INHOCO 2166 LIMITED 11 Oct 2000 — 14 Mar 2001
Accounts Submitted 16 Feb 2026 Next due 30 Jun 2026 13 days remaining
Confirmation Submitted 19 Dec 2025 Next due 24 Dec 2026 6 months remaining
Net assets £78M £25M 2025 year on year
Total assets £83M £26M 2025 year on year
Total Liabilities £5M £659K 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Victrex Technology Centre Hillhouse International Thornton Cleveleys Lancashire FY5 4QD

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for INVIBIO LIMITED (04088050), an active life sciences and medical technology company based in Cleveleys, United Kingdom. Incorporated 11 Oct 2000. Manufacture of plastics in primary forms. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Oct → 30 Sept 2025
Type full
Next accounts 30 Sept 2025
Due by 30 Jun 2026 13 days remaining

Balance Sheet & P&L (2014–2025)

Cash in Bank

£694.00k

Decreased by £1.54M (-69%)

Net Assets

£77.69M

Increased by £25.26M (+48%)

Total Liabilities

£5.33M

Increased by £659.00k (+14%)

Turnover

£41.96M

Decreased by £4.16M (-9%)

Employees

15

Debt Ratio

6%

Decreased by 2 (-25%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
30 Sept Year End
2024
30 Sept Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Grants 1

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Victrex Plc
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Victrex Plc

United Kingdom

Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent

Group Structure

Group Structure

VICTREX PLC united kingdom
INVIBIO LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
16 Feb 2026AccountsAnnual accounts made up to 30 Sept 2025
10 Feb 2026OfficersTermination of Jakob Oskar Sigurdsson as director on 6 Feb 2026
5 Jan 2026OfficersAppointment of James Mathew Routh as director on 1 Jan 2026
19 Dec 2025Confirmation StatementConfirmation statement made on 10 Dec 2025 with no updates
19 Aug 2025Change Of ConstitutionStatement Of Companys Objects
16 Feb 2026 Accounts

Annual accounts made up to 30 Sept 2025

10 Feb 2026 Officers

Termination of Jakob Oskar Sigurdsson as director on 6 Feb 2026

5 Jan 2026 Officers

Appointment of James Mathew Routh as director on 1 Jan 2026

19 Dec 2025 Confirmation Statement

Confirmation statement made on 10 Dec 2025 with no updates

19 Aug 2025 Change Of Constitution

Statement Of Companys Objects

Recent Activity

Latest Activity

Annual accounts made up to 30 Sept 2025

4 months ago on 16 Feb 2026

Termination of Jakob Oskar Sigurdsson as director on 6 Feb 2026

4 months ago on 10 Feb 2026

Appointment of James Mathew Routh as director on 1 Jan 2026

5 months ago on 5 Jan 2026

Confirmation statement made on 10 Dec 2025 with no updates

5 months ago on 19 Dec 2025

Statement Of Companys Objects

10 months ago on 19 Aug 2025